We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KFRC icon
3126
Kforce
KFRC
$1.02B
$718K ﹤0.01%
18,967
-3,029
-14% -$104K
LEVI icon
3127
Levi Strauss
LEVI
$9.44B
$716K ﹤0.01%
37,633
-14,924
-28% -$277K
CQP icon
3128
Cheniere Energy
CQP
$31.9B
$712K ﹤0.01%
15,667
+1,494
+11% +$66.4K
ENIA
3129
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$712K ﹤0.01%
78,053
+12,151
+18% +$102K
TRUP icon
3130
Trupanion
TRUP
$1.07B
$707K ﹤0.01%
27,819
+3,194
+13% +$93.6K
AAMI
3131
Acadian Asset Management
AAMI
$3.08B
$703K ﹤0.01%
70,982
-306,144
-81% -$3.11M
CSW
3132
CSW Industrials
CSW
$5.2B
$701K ﹤0.01%
10,152
+1,483
+17% +$102K
MCHB
3133
Mechanics Bancorp
MCHB
$3.72B
$701K ﹤0.01%
25,691
+2,492
+11% +$69.1K
AIMT
3134
DELISTED
Aimmune Therapeutics
AIMT
$699K ﹤0.01%
33,418
+2,385
+8% +$48.7K
EBIX
3135
DELISTED
Ebix Inc
EBIX
$699K ﹤0.01%
16,603
+1,712
+11% +$71.9K
ATNI icon
3136
ATN International
ATNI
$366M
$695K ﹤0.01%
11,899
-2,798
-19% -$160K
CYTK icon
3137
Cytokinetics
CYTK
$10.5B
$695K ﹤0.01%
61,093
+31,663
+108% +$397K
MLAB icon
3138
Mesa Laboratories
MLAB
$564M
$694K ﹤0.01%
2,924
+203
+7% +$46.9K
ORIT
3139
DELISTED
Oritani Financial Corp. New
ORIT
$694K ﹤0.01%
39,240
+15,423
+65% +$269K
NPK icon
3140
National Presto Industries
NPK
$870M
$688K ﹤0.01%
7,731
+683
+10% +$61.8K
COOP
3141
DELISTED
Mr. Cooper
COOP
$687K ﹤0.01%
64,759
+1,847
+3% +$16.6K
ANGO icon
3142
AngioDynamics
ANGO
$611M
$686K ﹤0.01%
37,219
+1,455
+4% +$28.5K
CMTL icon
3143
Comtech Telecommunications
CMTL
$50.3M
$686K ﹤0.01%
21,122
+639
+3% +$18.2K
INFN
3144
DELISTED
Infinera Corporation Common Stock
INFN
$686K ﹤0.01%
125,901
+19,856
+19% +$87.3K
ANIK icon
3145
Anika Therapeutics
ANIK
$258M
$685K ﹤0.01%
12,454
+3,425
+38% +$176K
CTBI icon
3146
Community Trust Bancorp
CTBI
$1.42B
$684K ﹤0.01%
16,059
+681
+4% +$28K
TR icon
3147
Tootsie Roll Industries
TR
$2.93B
$682K ﹤0.01%
22,584
-11,956
-35% -$360K
APHA
3148
DELISTED
Aphria Inc. Common Shares
APHA
$682K ﹤0.01%
131,342
-107,024
-45% -$680K
EPZM
3149
DELISTED
Epizyme, Inc
EPZM
$681K ﹤0.01%
66,031
+15,088
+30% +$190K
CARO
3150
DELISTED
Carolina Financial Corp.
CARO
$679K ﹤0.01%
19,100
+3,180
+20% +$111K

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.